$3.23 -0.12 (-3.58%)
11/27/2009 1:00 PM

DepoMed, Inc. (DEPO)

CAPS Rating: 2 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Results 1 - 20 of 22 1 2 Next »

Recs

0
Member Avatar sgh225 (38.57) Submitted: 11/11/2009 9:52:39 PM : Outperform Start Price: $3.18 DEPO Score: +1.96

strong drug development chain

Recs

0
Member Avatar TraderHater (52.48) Submitted: 11/3/2009 4:54:04 PM : Underperform Start Price: $3.07 DEPO Score: -1.36

Drugs er bad, mmm kay!!

Recs

0
Member Avatar SmallPimpin (98.28) Submitted: 10/13/2009 7:18:20 PM : Outperform Start Price: $3.73 DEPO Score: -14.19

Mmm...pharmaceuticals...

Recs

0
Member Avatar NoDoughBro (70.24) Submitted: 10/10/2009 1:05:18 AM : Outperform Start Price: $3.20 DEPO Score: +1.61

H1N1.

Recs

2
Member Avatar rwpaules (82.84) Submitted: 4/29/2009 9:09:53 AM : Outperform Start Price: $2.42 DEPO Score: -6.27

Phase III trials are currently under way on a drug for hot flashes. Standard treatment for hot flashes used to be hormone replacement therapy, which carries an increased risk of heart attack, stroke, and breast cancer. See http://www.medicinenet.com/alternative_treatments_for_hot_flashes/page2.htm

Current alternative treatments include SSRIs - selective seratonin reuptake inhibitors (primary indication in treating depression and anxiety), Clonodine (blood pressure medication, with annoying side effects such as dry mouth and constipation), various forms of progesterone (not all safe for long term use), and Depomed's Gabapentin (primary indication in treatment of seizures, well-tolerated by most women, main side effect being drowsiness). See http://www.medicinenet.com/alternative_treatments_for_hot_flashes/page3.htm

When studies were published early this decade linking HRT with serious health issues, the amount of money spent on HRT dropped significantly (actual numbers are in Depomed's 2008 Annual Report). Depomed stands to capture a significant portion of that market if Gabapentin proves effective, which is anticipated.

Recs

0
Member Avatar crapsshooter (86.95) Submitted: 2/6/2009 7:49:23 PM : Outperform Start Price: $2.40 DEPO Score: +6.36

I have been involved with this stock for awhile now and it has continued to increase in value slowly. the pace over the last week has quickened and I look for it to continue. Sales continue to rise and new products are being developed and licensed. I am begining to look at this company as a buy out caindidate for one of the big pharco's

Recs

1
Member Avatar ID10TS (< 20) Submitted: 8/21/2008 8:21:48 PM : Outperform Start Price: $4.27 DEPO Score: -12.26

< 10% Price gain in last Qtr. 6month and Year. <10 5 Year Growth Rate. <10 Net Profit Margin. Last price above 50 and 200 day moving average. Debt to QEquity < 1. P/E <10

Recs

1
Member Avatar NASAGeek (95.31) Submitted: 6/26/2008 9:21:55 PM : Outperform Start Price: $3.39 DEPO Score: +7.23

magicformulainvesting.com screen at $153M market cap, top 25 companies on June 26, 2008

Recs

0
Member Avatar Gurdjeppo (77.34) Submitted: 5/27/2008 4:11:32 PM : Outperform Start Price: $4.32 DEPO Score: -1.98

It's Depo-tastic!

Recs

0
Member Avatar REDSOXFANFORLIFE (34.03) Submitted: 3/12/2008 8:10:14 PM : Outperform Start Price: $2.69 DEPO Score: +31.97

Appears to be headed in the right direction. A portion of 2007 gains came from terminating promotion agreement with King Pharmaceuticals. However, sales and income numbers are on the rise. I'm taking a risk and keeping my fingers crossed

Recs

0
Member Avatar ESCalanderAI (85.05) Submitted: 3/3/2008 7:38:25 AM : Outperform Start Price: $3.37 DEPO Score: +10.08

EXP POS EARN

Recs

0
Member Avatar JCash22 (84.75) Submitted: 2/7/2008 10:42:29 AM : Outperform Start Price: $3.25 DEPO Score: +13.33

good fundamentals.

Recs

0
Member Avatar esso02 (52.84) Submitted: 12/31/2007 3:39:52 PM : Underperform Start Price: $3.29 DEPO Score: -20.48

Unknowen till FDA approval thoght it received a lot of $ due to

Recs

0
Member Avatar pjhurren (< 20) Submitted: 7/10/2007 7:13:33 PM : Outperform Start Price: $5.00 DEPO Score: -10.97

Wow just went down 60%. haha
see if they bounce back?

Recs

0
Member Avatar Mattd46612 (88.78) Submitted: 7/9/2007 11:04:47 PM : Outperform Start Price: $1.90 DEPO Score: +94.26

Just a matter of time before it blows up..

Recs

0
Member Avatar Brxcqqq (27.94) Submitted: 6/14/2007 12:04:40 PM : Underperform Start Price: $5.11 DEPO Score: +12.74

negative earnings, negative cash flow, can't understand for the life of me why this is a ***** stock. now watch me gets burned as it adds 160% in the next three weeks :-)

Recs

1
Member Avatar GrabBagGuy (< 20) Submitted: 6/11/2007 4:17:01 PM : Outperform Start Price: $4.31 DEPO Score: -1.94

I found this stock in December of 2006 when it was at $2.92 a share. Their product is unique and marketable and while the ride up (and down and up agian) can be frustrating I have it down as $6 per share before Christmas.

Recs

0
Member Avatar midbulllongbull (22.55) Submitted: 6/10/2007 9:33:26 PM : Outperform Start Price: $4.32 DEPO Score: -1.98

volatile 10~30%

Recs

0
Member Avatar dgoldmeier (31.94) Submitted: 4/14/2007 9:27:18 AM : Outperform Start Price: $3.99 DEPO Score: +1.52

A small pharma with good tech,pipeline, and patents.

Recs

0
Member Avatar wincopr (80.56) Submitted: 12/1/2006 12:08:06 PM : Outperform Start Price: $3.42 DEPO Score: +11.43

Great choice to invest. New drug will become pop.

Results 1 - 20 of 22 1 2 Next »

Featured Broker Partners